Blood platelets may hold key to faster ALS diagnosis
NCT ID NCT07479017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find specific markers in blood platelets that can help doctors diagnose ALS (Lou Gehrig's disease) more accurately and earlier. Researchers will compare 60 participants—30 with newly diagnosed ALS and 30 with other motor neuron diseases—to see if platelet tests can tell them apart. The goal is to develop a routine blood test that speeds up diagnosis and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS - AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University hospital, Limoges
Limoges, 87000, France
-
University hospital, Lyon
Lyon, 69000, France
-
university hospital, Tours
Tours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood markers may unlock early ALS detection — a study puts them to the test
- Brain implant aims to give voice to those trapped in silence
- Nasal spray aims to tame brain inflammation in ALS
- Robotic arm could help people with paralysis regain independence at home
- Experimental cell therapy tested in 3 ALS patients
- Gene therapy injection hopes to slow ALS